Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Mark D Sander, M.D.
Family Practice · FLORENCE, KY · NPI 1508893314
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 662 | 195 |
| Lisinopril | Lisinopril | 398 | 117 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 383 | 126 |
| Levothyroxine Sodium | Levothyroxine Sodium | 377 | 104 |
| Omeprazole | Omeprazole | 340 | 90 |
| Amlodipine Besylate | Amlodipine Besylate | 320 | 94 |
| Lorazepam | Lorazepam | 232 | 38 |
| Metoprolol Succinate | Metoprolol Succinate | 228 | 74 |
| Gabapentin | Gabapentin | 216 | 43 |
| Pantoprazole Sodium | Pantoprazole Sodium | 207 | 65 |
| Furosemide | Furosemide | 180 | 65 |
| Losartan Potassium | Losartan Potassium | 161 | 52 |
| Eliquis | Apixaban | 152 | 34 |
| Trazodone Hcl | Trazodone Hcl | 152 | 42 |
| Metformin Hcl | Metformin Hcl | 145 | 44 |
| Allopurinol | Allopurinol | 136 | 40 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 132 | 31 |
| Tamsulosin Hcl | Tamsulosin Hcl | 128 | 41 |
| Potassium Chloride | Potassium Chloride | 114 | 42 |
| Metoprolol Tartrate | Metoprolol Tartrate | 109 | 34 |
| Carvedilol | Carvedilol | 107 | 27 |
| Pravastatin Sodium | Pravastatin Sodium | 107 | 25 |
| Simvastatin | Simvastatin | 107 | 26 |
| Tizanidine Hcl | Tizanidine Hcl | 104 | 28 |
| Citalopram Hbr | Citalopram Hydrobromide | 103 | 25 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 96 | 19 |
| Metformin Hcl Er | Metformin Hcl | 96 | 32 |
| Hydrochlorothiazide | Hydrochlorothiazide | 93 | 31 |
| Ezetimibe | Ezetimibe | 81 | 23 |
| Meloxicam | Meloxicam | 81 | 28 |
| Pioglitazone Hcl | Pioglitazone Hcl | 81 | 27 |
| Zolpidem Tartrate | Zolpidem Tartrate | 81 | 14 |
| Buspirone Hcl | Buspirone Hcl | 79 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 69 | 19 |
| Spironolactone | Spironolactone | 69 | 22 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 68 | 14 |
| Alprazolam | Alprazolam | 67 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 67 | 22 |
| Fluticasone Propionate | Fluticasone Propionate | 62 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 58 | 17 |
| Meclizine Hcl | Meclizine Hcl | 57 | 22 |
| Synthroid | Levothyroxine Sodium | 57 | 16 |
| Januvia | Sitagliptin Phosphate | 55 | 17 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 55 | suppressed |
| Diazepam | Diazepam | 54 | 11 |
| Montelukast Sodium | Montelukast Sodium | 54 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 50 | 15 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 49 | 13 |
| Clonidine Hcl | Clonidine Hcl | 49 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 49 | 14 |
| Jardiance | Empagliflozin | 48 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 44 | 14 |
| Hydralazine Hcl | Hydralazine Hcl | 44 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 43 | 17 |
| Warfarin Sodium | Warfarin Sodium | 42 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 41 | suppressed |
| Xarelto | Rivaroxaban | 40 | suppressed |
| Torsemide | Torsemide | 39 | 16 |
| Fenofibrate | Fenofibrate | 38 | 11 |
| Tramadol Hcl | Tramadol Hcl | 37 | suppressed |
| Azithromycin | Azithromycin | 36 | 27 |
| Doxepin Hcl | Doxepin Hcl | 36 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 36 | 13 |
| Oxycodone Hcl | Oxycodone Hcl | 35 | suppressed |
| Valsartan | Valsartan | 35 | suppressed |
| Nifedipine Er | Nifedipine | 34 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 34 | suppressed |
| Pregabalin | Pregabalin | 34 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 34 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Finasteride | Finasteride | 33 | suppressed |
| Glimepiride | Glimepiride | 33 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 33 | 11 |
| Promethazine Hcl | Promethazine Hcl | 33 | suppressed |
| Ondansetron Odt | Ondansetron | 32 | 15 |
| Celecoxib | Celecoxib | 31 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 30 | suppressed |
| Clonazepam | Clonazepam | 29 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 29 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 28 | suppressed |
| Ozempic | Semaglutide | 28 | suppressed |
| Topiramate | Topiramate | 28 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 26 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 26 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 26 | suppressed |
| Methylprednisolone | Methylprednisolone | 26 | 25 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Baclofen | Baclofen | 25 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 25 | suppressed |
| Cephalexin | Cephalexin | 25 | 18 |
| Midodrine Hcl | Midodrine Hcl | 25 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 24 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Estradiol | Estradiol | 24 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 24 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 23 | suppressed |
| Lansoprazole | Lansoprazole | 23 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 21 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 21 | 21 |
| Atenolol | Atenolol | 20 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 20 | suppressed |
| Prednisone | Prednisone | 20 | suppressed |
| Ramipril | Ramipril | 20 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 19 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 19 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 18 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 18 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 18 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 18 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 17 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 17 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 16 | suppressed |
| Asa-Butalb-Caffeine-Codeine | Codeine/Butalbital/Asa/Caffein | 16 | suppressed |
| Bupropion Xl | Bupropion Hcl | 16 | suppressed |
| Memantine Hcl | Memantine Hcl | 16 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 15 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 15 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 15 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 14 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Repatha Sureclick | Evolocumab | 14 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 14 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 13 | suppressed |
| Movantik | Naloxegol Oxalate | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | suppressed |
| Eletriptan Hbr | Eletriptan Hydrobromide | 11 | suppressed |
| Levetiracetam | Levetiracetam | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error